Sanara MedTech (SMTI) Long-Term Investments (2018 - 2026)

Sanara MedTech (SMTI) has 8 years of Long-Term Investments data on file, last reported at $14.2 million in Q1 2026.

• Quarterly Long-Term Investments rose 32.5% year-over-year to $14.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.2 million (up 32.5% YoY) and the FY2025 annual result came in at $14.6 million, up 135.43% from the prior year.
• Long-Term Investments slipped to $14.2 million in Q1 2026, from $14.6 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $14.6 million in Q4 2025 to a low of $3.1 million in Q2 2022.
• A 5-year average of $6.5 million and a median of $3.1 million in 2022 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2022 — Long-Term Investments tumbled 38.53% — and 2025, when it surged 246.61%.
• Tracing SMTI's Long-Term Investments over 5 years: stood at $3.1 million in 2022, then changed by 0.0% to $3.1 million in 2023, then jumped by 101.44% to $6.2 million in 2024, then soared by 135.43% to $14.6 million in 2025, then retreated by 3.16% to $14.2 million in 2026.
• The last three Long-Term Investments figures came in at $14.2 million (Q1 2026), $14.6 million (Q4 2025), and $12.6 million (Q3 2025), per Business Quant data.